Belharra emerges with $130m and Genentech partnership 09-Jan-2023 By Ben Hargreaves The newly launched biotech is looking to develop small molecule drugs using its photoaffinity-based chemoproteomics platform.
Merck accelerator welcomes biotech start-ups specializing in AI and machine learning 08-Jul-2022 By Rachel Arthur Merck (MSD outside the US and Canada) is welcoming applications from early-stage biomedical start-ups for its newly launched Merck Digital Sciences Studio (MDSS): which seeks to support technologies for drug discovery and development.
